Analyst Conference Summaries

Biotechnology Investor Aids

Cidera Therapeutics
CTDX

conference date: February 25, 2021 press release only.

Coverage of Cidera has not yet begun, though I started buying the stock in March 2021.

2021
       
       

Cidera Therapeutics (CTDX) is a clinical-stage biotechnology company specializing in therapies for viral and fungal infections.

Cidera Therapeutics web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 INO
 IONS
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SGEN
 VBLT
 VSTM
 XLRN
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers